PU
Healthcare & Life Sciences
Pulmotect
United States
Pulmotect is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Pulmotect
Pulmotect is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Pulmotect develops immunotherapies to protect against respiratory infections by enhancing lung immune defenses.
Explore Pulmotect's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.